3.23
0.00%
0.00
시간 외 거래:
3.23
전일 마감가:
$3.23
열려 있는:
$3.2
하루 거래량:
2.19M
Relative Volume:
1.53
시가총액:
$554.33M
수익:
-
순이익/손실:
$-54.70M
주가수익비율:
-11.54
EPS:
-0.28
순현금흐름:
$-51.36M
1주 성능:
+0.62%
1개월 성능:
+3.19%
6개월 성능:
-13.17%
1년 성능:
-28.54%
사바라 Stock (SVRA) Company Profile
명칭
Savara Inc
전화
51285113796
주소
6836 BEE CAVE ROAD, AUSTIN, TX
SVRA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.23 | 554.33M | 0 | -54.70M | -51.36M | -0.33 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
사바라 Stock (SVRA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-13 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2024-02-15 | 개시 | JMP Securities | Mkt Outperform |
2023-11-07 | 개시 | Guggenheim | Buy |
2023-05-16 | 업그레이드 | Jefferies | Hold → Buy |
2023-03-31 | 다운그레이드 | Jefferies | Buy → Hold |
2021-03-16 | 개시 | Piper Sandler | Overweight |
2021-03-15 | 개시 | Oppenheimer | Outperform |
2019-06-13 | 재확인 | H.C. Wainwright | Buy |
2019-06-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2019-06-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2018-08-13 | 재개 | ROTH Capital | Neutral |
2018-01-03 | 개시 | Ladenburg Thalmann | Buy |
2017-09-27 | 재개 | ROTH Capital | Buy |
2017-09-22 | 개시 | Jefferies | Buy |
2017-09-11 | 개시 | JMP Securities | Mkt Outperform |
모두보기
사바라 주식(SVRA)의 최신 뉴스
Wells Fargo Initiates Coverage of Savara (SVRA) with Overweight Recommendation - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 6,141 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara: Rolling BLA Submission Of MOLBREEVI Generates Catalysts To Track (NASDAQ:SVRA) - Seeking Alpha
Savara (NASDAQ:SVRA) Now Covered by Analysts at Wells Fargo & Company - MarketBeat
Savara's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada
Savara's SWOT analysis: rare disease biotech stock poised for growth - Investing.com
Savara (NASDAQ:SVRA) Shares Up 5.6%Time to Buy? - MarketBeat
BNP Paribas Financial Markets Purchases 18,534 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
JMP Securities Reiterates "Market Outperform" Rating for Savara (NASDAQ:SVRA) - MarketBeat
Savara's MOLBREEVI Advances Toward First-Ever aPAP Treatment with FDA Rolling BLA Submission - StockTitan
Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Savara to Present at J.P. Morgan Healthcare Conference: Rare Respiratory Disease Breakthroughs in Focus - StockTitan
Savara's CFO David Lowrance sells $83,277 in stock By Investing.com - Investing.com South Africa
The Manufacturers Life Insurance Company Acquires 3,706 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara director Hawkins sells $26,568 in stock By Investing.com - Investing.com Australia
Savara director Hawkins sells $26,568 in stock - Investing.com India
Savara's SWOT analysis: molgramostim's promise buoys stock amid challenges - Investing.com
Savara Inc (NASDAQ:SVRA) CEO Matthew Pauls Sells 54,702 Shares - MarketBeat
Savara's CFO David Lowrance sells $83,277 in stock - Investing.com
Savara CEO Matthew Pauls sells $180,828 in stock - Investing.com
Savara CEO Matthew Pauls sells $180,828 in stock By Investing.com - Investing.com Australia
Charles Schwab Investment Management Inc. Boosts Stake in Savara Inc (NASDAQ:SVRA) - MarketBeat
Charles Schwab Investment Management Inc. Buys 642,259 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Janus Henderson Group PLC Decreases Stock Position in Savara Inc (NASDAQ:SVRA) - MarketBeat
Wellington Management Group LLP Acquires 1,608,522 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat
XChain, VARA’s Exclusive Transaction Monitoring Partner, Readies Rollout for Regional and Global VASPs - GlobeNewswire Inc.
Savara Inc (NASDAQ:SVRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Intech Investment Management LLC Invests $174,000 in Savara Inc (NASDAQ:SVRA) - Defense World
Savara's SWOT analysis: molgramostim's promise lifts rare disease stock - Investing.com
Savara (NASDAQ:SVRA) Shares Down 3.2%Here's What Happened - MarketBeat
Savara Inc. Announces Stock Awards for New Employees - MSN
Savara Inc (NASDAQ:SVRA) Stock Holdings Lifted by Vestal Point Capital LP - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Acquires 242,249 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat
Savara Grants 150,000 Share Inducement Awards to New Employees | SVRA Stock News - StockTitan
Savara Announces New Employment Inducement Grant - Business Wire
Savara to Present Phase 3 Trial Results for Breakthrough aPAP Treatment at BTS Meeting | SVRA Stock News - StockTitan
Jennison Associates LLC Acquires 1,001,296 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat
Independent Director of Savara Picks Up 4.5% More Stock - Simply Wall St
Savara Inc. Reports Third-Quarter Financial Results and Announces Key Regulatory Milestones - MSN
Insider Buying Alert: Joseph Mccracken Acquires 20,000 Shares of Savara Inc (SVRA) - GuruFocus.com
Savara director Joseph McCracken acquires $59,071 in common stock - Investing.com India
Savara director Joseph McCracken acquires $59,071 in common stock By Investing.com - Investing.com Canada
Director David Ramsay Acquires 100,000 Shares of Savara Inc (SVR - GuruFocus.com
Savara Inc director David Ramsay buys $287,600 in common stock - Investing.com
Savara Inc director David Ramsay buys $287,600 in common stock By Investing.com - Investing.com UK
Savara (NASDAQ:SVRA) Shares Down 8.5%Time to Sell? - MarketBeat
Prudential Financial Inc's Strategic Acquisition of Savara Inc S - GuruFocus.com
What is HC Wainwright's Estimate for Savara FY2024 Earnings? - MarketBeat
Evercore ISI Reiterates In-Line Rating for Savara (NASDAQ:SVRA) - Defense World
Savara (NASDAQ:SVRA) Reaches New 1-Year Low on Analyst Downgrade - MarketBeat
SVRA stock touches 52-week low at $3.27 amid market challenges - Investing.com India
사바라 (SVRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
사바라 주식 (SVRA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Pauls Matthew | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Sale |
3.31 |
54,702 |
180,828 |
1,536,379 |
Hawkins Richard J | Director |
Dec 16 '24 |
Sale |
3.32 |
8,000 |
26,569 |
67,241 |
자본화:
|
볼륨(24시간):